Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandra Allen

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Clinical Journal of Oncology Nursing|October 2, 2009
Suboptimal responses to imatinib in chronic myelogenous leukemia: what are they and how do they affect treatment?Sandra Allen-Bard
Advances in Skin & Wound Care|September 17, 2010
Diagnosis and management of foreign bodies in the skinJill E Winland-Brown, Sandra Allen
Progress in Community Health Partnerships : Research, Education, and Action|June 6, 2022
Evaluating A Local Community Collaborative Coalition: Utilizing the Wilder Collaborative Factors InventoryLaura Meyer, Pam Connor, Sandra Allen, et al.
Journal of Clinical Nursing|February 10, 2006
Patterns and frequency of anxiety in women undergoing gynaecological surgeryEloise Carr, Katrina Brockbank, Sandra Allen, et al.
American Journal of Hematology|October 31, 2003
Sickle cell patient with an acute chest syndrome and a negative chest X-ray: potential role of the ventilation and perfusion (V/Q) lung scanLawrence Feldman, Robert Gross, Jack Garon, et al.
American Journal of Hematology|November 20, 2004
Potential role of the ventilation and perfusion (V/Q) lung scan in the diagnosis of acute chest syndrome in adults with sickle cell diseaseNavleen Kaur, Bharat Motwani, Devaki Sivasubramaniam, et al.
Translational Behavioral Medicine|August 10, 2016
Patient factors associated with initiation of behavioral weight loss treatment: a prospective observational study in an integrated care settingMegan A McVay, William S Yancy, Christine N Scott, et al.
Leukemia Research|October 20, 2010
Arsenic trioxide and low-dose cytarabine for patients with intermediate-2 and high-risk myelodysplastic syndromeGail J Roboz, Ellen K Ritchie, Tania Curcio, et al.
Environmental Health Perspectives|January 24, 2009
A retrospective performance assessment of the developmental neurotoxicity study in support of OECD test guideline 426Susan L Makris, Kathleen Raffaele, Sandra Allen, et al.
Cancer|October 1, 2008
Arsenic trioxide and low-dose cytarabine in older patients with untreated acute myeloid leukemia, excluding acute promyelocytic leukemiaGail J Roboz, Ellen K Ritchie, Tania Curcio, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Clinical Journal of Oncology Nursing|October 2, 2009
Suboptimal responses to imatinib in chronic myelogenous leukemia: what are they and how do they affect treatment?Sandra Allen-Bard
Advances in Skin & Wound Care|September 17, 2010
Diagnosis and management of foreign bodies in the skinJill E Winland-Brown, Sandra Allen
Progress in Community Health Partnerships : Research, Education, and Action|June 6, 2022
Evaluating A Local Community Collaborative Coalition: Utilizing the Wilder Collaborative Factors InventoryLaura Meyer, Pam Connor, Sandra Allen, et al.
Journal of Clinical Nursing|February 10, 2006
Patterns and frequency of anxiety in women undergoing gynaecological surgeryEloise Carr, Katrina Brockbank, Sandra Allen, et al.
American Journal of Hematology|October 31, 2003
Sickle cell patient with an acute chest syndrome and a negative chest X-ray: potential role of the ventilation and perfusion (V/Q) lung scanLawrence Feldman, Robert Gross, Jack Garon, et al.
American Journal of Hematology|November 20, 2004
Potential role of the ventilation and perfusion (V/Q) lung scan in the diagnosis of acute chest syndrome in adults with sickle cell diseaseNavleen Kaur, Bharat Motwani, Devaki Sivasubramaniam, et al.
Translational Behavioral Medicine|August 10, 2016
Patient factors associated with initiation of behavioral weight loss treatment: a prospective observational study in an integrated care settingMegan A McVay, William S Yancy, Christine N Scott, et al.
Leukemia Research|October 20, 2010
Arsenic trioxide and low-dose cytarabine for patients with intermediate-2 and high-risk myelodysplastic syndromeGail J Roboz, Ellen K Ritchie, Tania Curcio, et al.
Environmental Health Perspectives|January 24, 2009
A retrospective performance assessment of the developmental neurotoxicity study in support of OECD test guideline 426Susan L Makris, Kathleen Raffaele, Sandra Allen, et al.
Cancer|October 1, 2008
Arsenic trioxide and low-dose cytarabine in older patients with untreated acute myeloid leukemia, excluding acute promyelocytic leukemiaGail J Roboz, Ellen K Ritchie, Tania Curcio, et al.
Pageof 2